BRIEF-Lundbeck presents Selincro phase III studies

STOCKHOLM, April 8 Mon Apr 8, 2013 2:03am EDT

Related Topics

STOCKHOLM, April 8 (Reuters) - H Lundbeck A/S : * Lundbeck presents new data on selincro from three phase III studies that

consistently show a significant reduction in alcohol consumption in alcohol

dependent patients with high risk drinking level

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.